Aurinia Pharmaceuticals Inc (AUPH)
5.03
-0.06
(-1.18%)
USD |
NASDAQ |
Apr 24, 16:00
5.01
-0.02
(-0.40%)
Pre-Market: 09:22
Aurinia Pharmaceuticals Cash and Short Term Investments (Quarterly): 350.49M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 350.49M |
| September 30, 2023 | 337.90M |
| June 30, 2023 | 350.71M |
| March 31, 2023 | 361.53M |
| December 31, 2022 | 389.39M |
| September 30, 2022 | 376.64M |
| June 30, 2022 | 391.74M |
| March 31, 2022 | 418.75M |
| December 31, 2021 | 466.08M |
| September 30, 2021 | 286.40M |
| June 30, 2021 | 318.74M |
| March 31, 2021 | 348.26M |
| December 31, 2020 | 398.33M |
| September 30, 2020 | 392.04M |
| June 30, 2020 | 264.35M |
| March 31, 2020 | 286.12M |
| December 31, 2019 | 306.02M |
| September 30, 2019 | 134.54M |
| June 30, 2019 | 131.49M |
| March 31, 2019 | 144.33M |
| December 31, 2018 | 125.86M |
| September 30, 2018 | 138.88M |
| June 30, 2018 | 150.20M |
| March 31, 2018 | 159.13M |
| December 31, 2017 | 173.46M |
| Date | Value |
|---|---|
| September 30, 2017 | 182.41M |
| June 30, 2017 | 189.79M |
| March 31, 2017 | 202.12M |
| December 31, 2016 | 39.65M |
| September 30, 2016 | 15.38M |
| June 30, 2016 | 12.12M |
| March 31, 2016 | 10.53M |
| December 31, 2015 | 15.75M |
| September 30, 2015 | 20.58M |
| June 30, 2015 | 25.74M |
| March 31, 2015 | 29.04M |
| December 31, 2014 | 32.70M |
| September 30, 2014 | 35.53M |
| June 30, 2014 | 39.09M |
| March 31, 2014 | 43.29M |
| December 31, 2013 | 1.821M |
| September 30, 2013 | 4.502M |
| June 30, 2013 | 0.4543M |
| March 31, 2013 | 0.0334M |
| December 31, 2012 | 0.185M |
| September 30, 2012 | 0.2885M |
| June 30, 2012 | 1.350M |
| March 31, 2012 | 3.346M |
| December 31, 2011 | 5.924M |
| September 30, 2011 | 7.333M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
131.49M
Minimum
Jun 2019
466.08M
Maximum
Dec 2021
332.08M
Average
350.49M
Median
Dec 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Lexaria Bioscience Corp | 4.793M |
| Acasti Pharma Inc | 25.11M |
| Edesa Biotech Inc | 4.268M |
| Xenon Pharmaceuticals Inc | 638.08M |
| ESSA Pharma Inc | 142.12M |